Open original FDA record ↗Recall record
- FDA identifier
- Z-1864-2021
- Company in FDA record
- GE Healthcare, LLC
- FDA classification date
- Jun 15, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The IGS system can experience a single vertical line defect where the vertical line divides and horizontally shifts live monitor images into two unequal image parts within the monitor display screen.
Source facts
- Action
- The recalling firm issued letters dated 4/19/2021 via traceable mail on 4/20/21 and issued an additional letter dated 4/28/2021 to correct an omission of serial numbers (only sent to the affected consignees).
- Initiated
- 2021-04-19
- Root cause
- Component change control
- Terminated
- 2023-08-31
- Distribution
- Worldwide distribution - US Nationwide distribution in the states of CA, CO, FL, GA, KY, LA, MA, MO, MS, NC, NJ, NV, NY, PA, SC, TN, TX, VA, WA, and WI. Government distribution was made and potentially military distribution was made. The countries of Algeria, Argentina, Canada, China, Dominican Republic, Finland, France, Germany, Hungary, India, Indonesia, Iran, Iraq, Italy, Japan, Korea, Kuwait, Mexico, Moldova, Morocco, Poland, Russia, Spain, Sudan, Taiwan, Turkey, United Arab Emirates, United Kingdom, and Uzbekistan.
- Recall number
- Z-1864-2021
- Recall status
- Terminated
- CDRH record ID
- 187261
- FDA classified
- 2021-06-15
- Recall event number
- 87863